Clearing minimal residual disease with rituximab consolidation therapy

被引：11

作者：

Brugger, W ^{[1
]}

机构：

[1] Univ Tubingen, Dept Hematol Oncol Immunol & Infect Dis, D-78050 Schwenningen, Germany

来源：

SEMINARS IN ONCOLOGY | 2004年 / 31卷 / 01期

关键词：

D O I：

10.1053/j.seminoncol.2003.12.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：33 / 37

页数：5

共 21 条

[1] Should we purge? [J].

Bensinger, WI .

BONE MARROW TRANSPLANTATION, 1998, 21 (02) :113-115

[2] High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma [J].

Bierman, PJ ;

Vose, JM ;

Anderson, JR ;

Bishop, MR ;

Kessinger, A ;

Armitage, JO .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :445-450

[3]

Bolwell BJ, 2001, BLOOD, V98, p738A

[4]

BOSCH F, 1994, BLOOD, V84, P2726

[5]

Brugger W, 2002, BLOOD, V100, p644A

[6]

Buckstein R, 1999, SEMIN ONCOL, V26, P115

[7]

Buckstein RJ, 2002, BLOOD, V100, p647A

[8]

Chan WC, 1997, BLOOD, V89, P3909

[9] Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma [J].

Freedman, AS ;

Neuberg, D ;

Mauch, P ;

Soiffer, RJ ;

Anderson, KC ;

Fisher, DC ;

Schlossman, R ;

Alyea, EP ;

Takvorian, T ;

Jallow, H ;

Kuhlman, C ;

Ritz, J ;

Nader, LM ;

Gribben, JG .

BLOOD, 1999, 94 (10) :3325-3333

[10]

Goldberg SL, 1999, BLOOD, V94, p141A

← 1 2 3 →